Orphazyme reveals survival plan: Possible buyers and investors have been contacted

Possible buyers and investors have been contacted as part of Orphazyme’s plan for survival. If they do not take the bait, the company will struggle to make ends meet, the plan says.
Photo: Orphazyme/PR
Photo: Orphazyme/PR
by christian bundgaard, translated by catherine brett

Embattled biotech company Orphazyme has revealed its reconstruction plans, made with legal firm Gorissen Federspiel, to save the company from the grips of bankruptcy.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading